Shine-On BioMedical Co.,Ltd. (TPEX: 6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.80
-0.10 (-0.15%)
Dec 20, 2024, 2:33 PM CST
4.05%
Market Cap 3.33B
Revenue (ttm) 9.52M
Net Income (ttm) -70.83M
Shares Out 49.80M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,101
Open 67.00
Previous Close 66.90
Day's Range 65.80 - 67.30
52-Week Range 61.10 - 69.60
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Apr 18, 2025

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 19
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.